Preface |
|
xiii | |
The Author |
|
xv | |
|
Chapter 1 Omics and Microarrays Revisited |
|
|
1 | (30) |
|
|
1 | (2) |
|
|
3 | (1) |
|
|
3 | (3) |
|
|
6 | (1) |
|
The Biomedical Testing Continuum |
|
|
6 | (1) |
|
Biotech Sector Trends Revisited |
|
|
7 | (1) |
|
|
8 | (4) |
|
The Role for Gene Expression Microarrays in Drug Discovery |
|
|
12 | (3) |
|
Toxicogenomic Applications |
|
|
15 | (1) |
|
Proteomics Today-The Great Challenge |
|
|
16 | (1) |
|
The Potential Role for Protein Microarrays in Drug Discovery |
|
|
17 | (1) |
|
Critical Issues with Protein Microarrays |
|
|
18 | (1) |
|
Stability and Performance |
|
|
18 | (2) |
|
|
20 | (1) |
|
|
20 | (1) |
|
|
21 | (1) |
|
Protein Profiling Formats |
|
|
22 | (1) |
|
Near-Term Biomedical Applications |
|
|
22 | (1) |
|
|
22 | (1) |
|
Autoimmune Diseases and Allergy |
|
|
23 | (1) |
|
Future Medicine-Pharmacoproteomics or Pharmacogenomics? |
|
|
24 | (3) |
|
|
27 | (4) |
|
Chapter 2 Commercial Microarrays |
|
|
31 | (26) |
|
|
31 | (1) |
|
|
31 | (8) |
|
Ex Situ or Spotted DNA Arrays |
|
|
39 | (1) |
|
Content for DNA Microarrays |
|
|
40 | (1) |
|
Suppliers of DNA Microarrays |
|
|
41 | (1) |
|
Comparison of Commercial DNA Microarrays |
|
|
41 | (3) |
|
Commercial Protein Arrays |
|
|
44 | (1) |
|
|
45 | (1) |
|
An Open Platform Approach |
|
|
46 | (1) |
|
A2 Multiplex ELISA System |
|
|
46 | (2) |
|
Three-Dimensional (3D) and Four-Dimensional (4D) Chips |
|
|
48 | (1) |
|
|
49 | (2) |
|
|
51 | (3) |
|
|
54 | (3) |
|
Chapter 3 Supports and Surface Chemistries |
|
|
57 | (46) |
|
|
57 | (1) |
|
|
57 | (1) |
|
|
58 | (3) |
|
|
61 | (1) |
|
|
61 | (3) |
|
|
64 | (4) |
|
|
68 | (3) |
|
|
71 | (1) |
|
|
71 | (1) |
|
|
72 | (1) |
|
|
72 | (9) |
|
|
81 | (4) |
|
Preparation of Glass Substrates for Derivatization |
|
|
85 | (3) |
|
Variation in the Performance of Glass Slide-Based Antibody Microarrays |
|
|
88 | (2) |
|
Comparison of Different Surface Chemistries for the Immobilization of Auto-Antigens |
|
|
90 | (1) |
|
Click Chemistry as an Immobilization Strategy |
|
|
91 | (2) |
|
Oxygen Plasma-Mediated Modification of DVD-R Disks for Tethering of Oligonucleotides |
|
|
93 | (3) |
|
Construction of Lipid Bilayer Microarrays |
|
|
96 | (1) |
|
|
97 | (1) |
|
|
98 | (5) |
|
Chapter 4 Arraying Processes |
|
|
103 | (66) |
|
|
103 | (1) |
|
Creating Spotted Microarrays |
|
|
104 | (1) |
|
|
104 | (1) |
|
|
105 | (1) |
|
|
106 | (1) |
|
Microarray Printing Mechanisms |
|
|
106 | (7) |
|
|
113 | (2) |
|
|
115 | (6) |
|
|
121 | (1) |
|
|
121 | (4) |
|
|
125 | (3) |
|
|
128 | (2) |
|
|
130 | (3) |
|
|
133 | (1) |
|
Optimization of Probe Concentration |
|
|
133 | (1) |
|
Protocols for Printing Nucleic Acids |
|
|
134 | (1) |
|
|
134 | (1) |
|
|
135 | (1) |
|
|
136 | (1) |
|
|
136 | (2) |
|
|
138 | (1) |
|
|
138 | (3) |
|
|
141 | (3) |
|
|
144 | (2) |
|
Protocols for Printing Proteins |
|
|
146 | (2) |
|
|
148 | (5) |
|
Newer Methods for Printing |
|
|
153 | (1) |
|
|
153 | (2) |
|
|
155 | (2) |
|
Microarray-to-Microarray Slide Snapping Transfer |
|
|
157 | (1) |
|
Micro-Contact (CP) Printing |
|
|
158 | (3) |
|
Creation of Peptide Nucleic Acid Microarrays by CP |
|
|
161 | (2) |
|
Covalent Subtractive Print by CP |
|
|
163 | (1) |
|
|
164 | (5) |
|
Chapter 5 Gene Expression: Microarray-Based Applications |
|
|
169 | (48) |
|
|
169 | (1) |
|
Applications Demonstrating DNA Microarray Utility |
|
|
169 | (1) |
|
|
169 | (11) |
|
Biomedical Research Applications |
|
|
180 | (1) |
|
|
180 | (2) |
|
|
182 | (3) |
|
|
185 | (12) |
|
|
197 | (3) |
|
|
200 | (3) |
|
|
203 | (1) |
|
The Utility of Gene Expression Microarrays in Micro-RNA Analysis |
|
|
204 | (2) |
|
The Nature of Platform-to-Platform Disparity |
|
|
206 | (4) |
|
Array-Based Comparative Genomic Hybridization |
|
|
210 | (1) |
|
Karyotype, Fluorescence in situ Hybridization (FISH), Comparative Genomic Hybridization (CGH), or Array-CGH? |
|
|
211 | (2) |
|
|
213 | (4) |
|
Chapter 6 Protein Microarray Applications |
|
|
217 | (50) |
|
|
217 | (1) |
|
|
217 | (6) |
|
Applications Demonstrating Protein Microarray Utility |
|
|
223 | (1) |
|
Microtiter-Based Antibody Arrays |
|
|
224 | (1) |
|
|
225 | (3) |
|
|
228 | (7) |
|
Measuring Microarray Performance |
|
|
235 | (1) |
|
Sensitivity and Dynamic Range |
|
|
235 | (7) |
|
Other Microarray Formats Useful for Proteomic Applications |
|
|
242 | (1) |
|
|
242 | (2) |
|
|
244 | (2) |
|
|
246 | (3) |
|
|
249 | (5) |
|
Peptide Arrays for Antibody Detection |
|
|
254 | (1) |
|
Phage-Display Antibody Selection |
|
|
255 | (1) |
|
Protein Kinase Microarray |
|
|
255 | (1) |
|
Protein Microarrays Useful in Auto-Antibody Screening |
|
|
256 | (2) |
|
Dual Labeling of Targets for Increased Sensitivity and Specificity |
|
|
258 | (1) |
|
The Depletion of Highly Abundant Proteins from Serum Deemed Unnecessary |
|
|
259 | (1) |
|
Competitive ELISA by Protein Microarray |
|
|
259 | (1) |
|
The Issue of Cross-Reactivity in a Protein Microarray Sandwich ELISA |
|
|
260 | (3) |
|
|
263 | (4) |
|
Chapter 7 Multiplex Assays |
|
|
267 | (28) |
|
|
267 | (1) |
|
|
267 | (1) |
|
|
267 | (4) |
|
Multiplex Polymerase Chain Reaction (PCR) |
|
|
271 | (1) |
|
Multiplex PCR Compared to DNA Microarray |
|
|
272 | (1) |
|
|
272 | (2) |
|
Nucleic Acid Lateral Flow Immunoassay (NALFIA) |
|
|
274 | (2) |
|
|
276 | (1) |
|
Multiplex Bead-Based Assays |
|
|
276 | (1) |
|
Multiplex Bead-Based Assay Compared to the ELISA |
|
|
277 | (2) |
|
Multiplex Bead-Based Herpes Simplex Virus (HSV) Assay Compares Favorably with Serological Methods |
|
|
279 | (2) |
|
|
281 | (1) |
|
Observed Differences between ELISA and Bead-Based Multiplex |
|
|
281 | (1) |
|
Combined Multiplex PCR and Multiplex Bead-Based Assay |
|
|
282 | (1) |
|
|
283 | (1) |
|
Multiplex Microarray Plate Assay Compared to the ELISA |
|
|
284 | (2) |
|
A Lack of Standardization |
|
|
286 | (1) |
|
Label Free Detection of a Multiplex Small Molecule Microarray |
|
|
286 | (2) |
|
Adoption of Multiplex Assays |
|
|
288 | (2) |
|
|
290 | (1) |
|
|
291 | (4) |
Index |
|
295 | |